Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Half year trading update

3 Aug 2015 07:00

RNS Number : 8042U
Toumaz Limited
03 August 2015
 



3 August 2015

 

Toumaz Limited

 

Half year trading update

 

Toumaz Limited (AIM: TMZ, 'Toumaz', or the 'Group'), a pioneer in low-power, wireless semiconductor technologies for digital audio and healthcare, provides the following trading update for the six months ended 30 June 2015. 

 

Financial highlights

 

· Revenues up 30% at £14.0m (H1 2014: £10.8m)

· Gross profit up 40% to £6.3m (H1 2014: £4.5m)

· EBITDA loss £5.5m (H1 2014: loss £5.6m)

· R&D expenditure: £6.4m (H1 2014: £5.1m)

· As at 30 June 2015, the cash balance was £5.5m (31 December 2015: £12.5 million)

 

Overview

 

The Digital Audio division has performed strongly with revenues up 34% at £13.8m (£10.3m in H1 2014). Growth has been driven by the international expansion of digital radio and the rapid emergence of the connected audio market. Toumaz is well-positioned in both sectors and the recent co-development agreement with Google is a strong endorsement of the Group's forthcoming next generation connected audio solution.

 

In Healthcare, the commercial delivery of SensiumVitals® remains slow with revenues of £0.2m (£0.5m in H1 2014); but based on recent trials the Board remains confident that the fundamental economic and clinical value of the system will be demonstrated.

 

Anthony Sethill, CEO of Toumaz, commented:

 

"We are delighted with the growth of our Digital Audio business. Our co-development agreement with Google will be an important factor in further developing our position in connected audio.

 

"We are trialling SensiumVitals® in a number of hospitals, including the Queen Elizabeth Hospital Birmingham and St James's Hospital, Leeds. However, these complex systems for the healthcare environment need considerable amounts of data and trialling, which have delayed our commercial roll out.

 

"Overall, given the strong performance by Digital Audio, we remain on course to continue to grow the business in the second half of the year."

 

Enquiries:

 

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Peel Hunt LLP (Nominated Adviser and Broker)

+44 (0)20 7418 8900

Richard Kauffer/Euan Brown

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Chantal Woolcock

 

About Toumaz (www.toumaz.com)

 

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and digital audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital radio and connected audio devices.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSRDAILVIE
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSTrading update
13th Feb 20127:00 amRNSPlacing raises £11.2m
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSYear End Trading Update
1st Feb 20117:00 amRNSTELRAN Launch
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.